These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

311 related items for PubMed ID: 16931258

  • 1. Preoperative ketorolac tromethamine 0.4% in phacoemulsification outcomes: pharmacokinetic-response curve.
    Donnenfeld ED, Perry HD, Wittpenn JR, Solomon R, Nattis A, Chou T.
    J Cataract Refract Surg; 2006 Sep; 32(9):1474-82. PubMed ID: 16931258
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Efficacy and tolerability of preservative-free and preserved diclofenac and preserved ketorolac eyedrops after cataract surgery.
    Maca SM, Amon M, Findl O, Kahraman G, Barisani-Asenbauer T.
    Am J Ophthalmol; 2010 May; 149(5):777-84. PubMed ID: 20152959
    [Abstract] [Full Text] [Related]

  • 5. Comparative effects of ketorolac 0.5% or diclofenac 0.1% ophthalmic solutions on inflammation after cataract surgery.
    Flach AJ, Dolan BJ, Donahue ME, Faktorovich EG, Gonzalez GA.
    Ophthalmology; 1998 Sep; 105(9):1775-9. PubMed ID: 9754191
    [Abstract] [Full Text] [Related]

  • 6. Ketorolac tromethamine LS 0.4% versus nepafenac 0.1% in patients having cataract surgery. Prospective randomized double-masked clinical trial.
    Duong HV, Westfield KC, Chalkley TH.
    J Cataract Refract Surg; 2007 Nov; 33(11):1925-9. PubMed ID: 17964399
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Safety and efficacy of ketorolac tromethamine 0.4% ophthalmic solution in post-photorefractive keratectomy patients.
    Solomon KD, Donnenfeld ED, Raizman M, Sandoval HP, Stern K, VanDenburgh A, Cheetham JK, Schiffman R, Ketorolac Reformulation Study Groups 1 and 2.
    J Cataract Refract Surg; 2004 Aug; 30(8):1653-60. PubMed ID: 15313287
    [Abstract] [Full Text] [Related]

  • 9. Effect of prophylactic nonsteroidal antiinflammatory drugs on cystoid macular edema assessed using optical coherence tomography quantification of total macular volume after cataract surgery.
    Almeida DR, Johnson D, Hollands H, Smallman D, Baxter S, Eng KT, Kratky V, ten Hove MW, Sharma S, El-Defrawy S.
    J Cataract Refract Surg; 2008 Jan; 34(1):64-9. PubMed ID: 18165083
    [Abstract] [Full Text] [Related]

  • 10. Efficacy and safety profile of ketorolac 0.5% ophthalmic solution in the prevention of surgically induced miosis during cataract surgery.
    Stewart R, Grosserode R, Cheetham JK, Rosenthal A.
    Clin Ther; 1999 Apr; 21(4):723-32. PubMed ID: 10363737
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of indomethacin 0.1% eye drops compared with ketorolac 0.5% eye drops in the management of ocular inflammation after cataract surgery.
    Weber M, Kodjikian L, Kruse FE, Zagorski Z, Allaire CM.
    Acta Ophthalmol; 2013 Feb; 91(1):e15-21. PubMed ID: 22970738
    [Abstract] [Full Text] [Related]

  • 14. Comparison of ketorolac 0.4% and nepafenac 0.1% for the prevention of cystoid macular oedema after phacoemulsification: prospective placebo-controlled randomised study.
    Tzelikis PF, Vieira M, Hida WT, Motta AF, Nakano CT, Nakano EM, Alves MR.
    Br J Ophthalmol; 2015 May; 99(5):654-8. PubMed ID: 25385061
    [Abstract] [Full Text] [Related]

  • 15. Prophylactic use of ketorolac tromethamine in cataract surgery: a randomized trial.
    Ticly FG, Lira RP, Zanetti FR, Machado MC, Rodrigues GB, Arieta CE.
    J Ocul Pharmacol Ther; 2014 Aug; 30(6):495-501. PubMed ID: 24735005
    [Abstract] [Full Text] [Related]

  • 16. Treatment of acute pseudophakic cystoid macular edema: Diclofenac versus ketorolac.
    Rho DS.
    J Cataract Refract Surg; 2003 Dec; 29(12):2378-84. PubMed ID: 14709300
    [Abstract] [Full Text] [Related]

  • 17. Ketorolac tromethamine 0.5% ophthalmic solution in the treatment of moderate to severe ocular inflammation after cataract surgery: a randomized, vehicle-controlled clinical trial.
    Heier J, Cheetham JK, Degryse R, Dirks MS, Caldwell DR, Silverstone DE, Rosenthal A.
    Am J Ophthalmol; 1999 Mar; 127(3):253-9. PubMed ID: 10088733
    [Abstract] [Full Text] [Related]

  • 18. Comparison of ketorolac tromethamine 0.5% and loteprednol etabonate 0.5% for inflammation after phacoemulsification: prospective randomized double-masked study.
    Holzer MP, Solomon KD, Sandoval HP, Vroman DT.
    J Cataract Refract Surg; 2002 Jan; 28(1):93-9. PubMed ID: 11777716
    [Abstract] [Full Text] [Related]

  • 19. Prophylactic nepafenac and ketorolac versus placebo in preventing postoperative macular edema after uneventful phacoemulsification.
    Almeida DR, Khan Z, Xing L, Bakar SN, Rahim K, Urton T, El-Defrawy SR.
    J Cataract Refract Surg; 2012 Sep; 38(9):1537-43. PubMed ID: 22795976
    [Abstract] [Full Text] [Related]

  • 20. Preoperative topical indomethacin to prevent pseudophakic cystoid macular edema.
    Yavas GF, Oztürk F, Küsbeci T.
    J Cataract Refract Surg; 2007 May; 33(5):804-7. PubMed ID: 17466852
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.